Colonic drug delivery systems based on natural polysaccharides and their evaluation

Mini-Reviews in Medicinal Chemistry

Volumn 13, Issue 13, 2013, Pages 1982-1991

  Pachuau, Lalduhsanga ^a   Mazumder, Bhaskar ^b  

^a Regional Institute of Paramedical and Nursing Sciences (RIPANS)   (India)

^b DIBRUGARH UNIVERSITY   (India)

Author keywords

Scintigraphy; Colonic drug delivery; Crohn's disease; Polysaccharides; Ulcerative colitis; X ray studies

Indexed keywords

ALGAROBA; ALGINIC ACID; AMINOSALICYLIC ACID; AMYLOSE; BUDESONIDE; CAFFEINE; CALCIUM PECTINATE; CHITOSAN; CHONDROITIN SULFATE; DEXTRAN; EUDRAGIT; FLUOROURACIL; GUAR GUM; INDOMETACIN; MESALAZINE; PECTIN; POLYSACCHARIDE; UNCLASSIFIED DRUG; VANCOMYCIN; XANTHAN;

ARTICLE; BACTEROIDES; BIFIDIBACTERIUM; COLON; COLON FLORA; CONTROLLED DRUG RELEASE; DAHLIA; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; DRUG TARGETING; ENTERIC COATED TABLET; ENTERITIS; GAMMA SCINTIGRAPHY; HUMAN; HYDROGEL; MICROCAPSULE; NONHUMAN; RADIOGRAPHY; TABLET COMPRESSION; ULCERATIVE COLITIS; XANTHOMONAS CAMPESTRIS;

ANIMALS; BIOLOGICAL PRODUCTS; COLON; DRUG DELIVERY SYSTEMS; HUMANS; POLYSACCHARIDES;

EID: 84888069156     PISSN: 13895575     EISSN: 18755607     Source Type: Journal    
DOI: 10.2174/13895575113136660085     Document Type: Article

References (87)

1. Kinget, R.; Kalala, W.; Vervoort, L.; Mooter, G.V.D. Colonic drug targeting. J. Drug Target., 1998, 6, 129-149.
2. Jain, A.; Gupta, Y.; Jain, S.K. Perspective of biodegradable natural polysaccharides for site-specific drug delivery to the colon. J. Pharm. Pharm. Sci., 2007, 10, 86-128.
3. Wood, E.; Wilson, C.; Hardy, J. The spreading of foam and solution enemas. Int. J. Pharmacol., 1985, 25, 191-197.
4. Ibekwe, V.C.; Khela, M.K.; Evans, D.F.; Basit, A.W. A new concept in colonic drug targeting: a combined pH-responsive and bacterially-triggered drug delivery technology. Aliment. Pharmacol. Ther., 2008, 28, 911-916.
5. Yang, L. Biorelevant dissolution testing of colon specific delivery systems activated by colonic microflora. J. Control. Release, 2008, 125, 77-86.
6. Rao, K.S.V.K.; Naidu, B.V.K.; Subha, M.C.S.; Sairam, M.; Aminabhavi, T.M. Novel chitosan-based pH-sensitive interpenetrating network microgels for the controlled release of cefadroxil. Carbohydr. Polym., 2006, 66, 333-344.
7. Mundargi, R.C.; Patil, S.A.; Aminabhavi, T.M. Evaluation of acrylamide-grafted-xanthan gum copolymer matrix tablets for oral controlled delivery of antihypertensive drugs. Carbohydr. Polym., 2007, 69, 130-141.
8. Maestrelli, F.; Cirri, M.; Corti, G.; Mennini, N.; Mura, P. Development of enteric-coated calcium pectinate microspheres intended for colonic delivery. Eur. J. Pharm. Biopharm., 2008, 69, 508-518.
9. Karrout, Y.; Neut, C.; Wils, D.; Siepmann, F.; Deremaux, L.; Desreumaux, P.; Siepmann, J. Characterization of ethylcellulose: starch-based film coatings for colon targeting. Drug Develop. Ind. Pharm., 2009, 35, 1190-1200.
10. Yehia, S.A.; Elshafeey, A.H.; Elsayed, I. Pulsatile systems for colon targeting of budesonide: In vitro and in vivo evaluation. Drug Deliv., 2011, 18, 620-630.
11. Schellekens, R.C.A.; Baltink, J.H.; Woesthuis, E.M.; Stellaard, F.; Kosterink, J.G.W.; Woerdenbag, H.J.; Frijlink, H.W. Film coated tablets (ColoPulse technology) for targeted delivery in the lower intestinal tract: Influence of the core composition on release characteristics. Pharm. Develop. Technol., 2012, 17, 40-47.
12. Ahmadi, F.; Varshosaz, J.; Emami, J.; Tavakoli, N.; Minaiyan, M.; Mahzouni, P.; Dorkoosh, F. Preparation and in vitro/in vivo evaluation of dextran matrix tablets of budesonide in experimental ulcerative colitis in rats. Drug Deliv., 2011, 18, 122-130.
13. Rubinstein, A. Colonic drug delivery. Drug Discov. Today Technol., 2005, 2, 33-37.
14. Krishnaiah, Y.S.R.; Muzib, Y.I.; Rao, G.S.; Bhaskar, P.; Satyanarayana, V. Studies on the Development of Colon Targeted Oral Drug Delivery Systems for Ornidazole in the Treatment of Amoebiasis. Drug Deliv., 2003, 10, 111-117.
15. Krishnaiah, Y.S.R.; Satyanarayana, V.; Kumar, B.D.; Karthikeyan, R.S.; Bhaskar, P. in vivo pharmacokinetics in human volunteers: oral administered guar gum-based colon-targeted 5-fluorouracil tablets. Eur. J. Pharm. Sci., 2003, 19, 355-362.
16. Sullad, A.G.; Manjeshwar, L.S.; Aminabhavi, T.M. Microspheres of carboxymethyl guar gum for in vitro release of abacavir sulfate: Preparation and characterization. J. Appl. Polym. Sci., 2011, 122, 452-460.
17. Rowe, R.C.; Sheskey, P.J.; Owen, S.C. Handbook of pharmaceutical excipients, 5th ed.; Pharmaceutical Press: London, 2006.
18. Tomlin, A.; Read, N.W.; Edwards, C.A.; Duerden, B.I. The degradation of guar gum by a fecal incubation system. Br. J. Nutr., 1986, 55, 481-486.
19. Krishnaiah, Y.S.R.; Satyanarayana, V.; Kumar, B.D.; Karthikeyan, R.S. In vitro drug release studies on guar gum-based colon targeted oral drug delivery systems of 5-fluorouracil. Eur. J. Pharm. Sci., 2002, 16, 185-192.
20. Krishnaiah, Y.S.R.; Satyanarayana, S.; Prasad, Y.V.R. Studied of guar gum compression coated 5-aminosalicylic acid tablets for colon specific drug delivery. Drug Develop. Ind. Pharm., 1999, 25, 651-657.
21. Rubinstein, A.; Radai, R.; Ezra, M.; Pathak, S.; Rokem, J.S. In vitro evaluation of calcium pectinate: A potential colon-specific drug delivery carrier. Pharm. Res., 1993, 10, 258-263.
22. Zhang, L.; Cao, F.; Ding, B.; Li, Q.; Xi, Y.; Zhai, G. Eudragit S100 coated calcium pectinate microspheres of curcumin for colon targeting. J. Microencapsul., 2011, 28, 659-667.
23. Wei, H.; Qing, D.; Ying, C.D.; Bai, X.; Fang, F.L. In-vitro and invivo studies of pectin/ethylcellulose film-coated pellets of 5-fluorouracil for colonic targeting. J. Pharm. Pharmacol., 2008, 60, 35-44.
24. Ugurlu, T.; Turkoglu, M.; Gurer, U.S.; Akarsu, B.G. Colonic delivery of compression coated nisin tablets using pectin/HPMC polymer mixture. Eur. J. Pharm. Biopharm., 2007, 67, 202-210.
25. Turkoglu, M.; Ugurlu, T. In vitro evaluation of pectin-HPMC compression coated 5-aminosalicylic acid tablets for colonic delivery. Eur. J. Pharm. Biopharm., 2002, 53, 65-73.
26. Ahrabi, S.F.; Madsen, G.; Dyrstad, K.; Sande, S.A.; Graffner, C. Development of pectin matrix tablets for colonic delivery of model drug ropivacaine. Eur. J. Pharm. Sci., 2000, 10, 43-52.
27. Macfarlane, G.T.; Englyst, H.N. Starch utilization by the human large intestinal microflora. J. Appl. Microbiol., 1986, 60, 195-201.
28. Siew, L.F.; Basit, A.W.; Newton, J.M. The potential of organicbased amylose-ethylcellulose film coatings as oral colon-specific drug delivery systems. AAPS PharmSciTech., 2000, 1, 22.
29. Tuleu, C.; Basit, A.W.; Waddington, W.A.; Ell, P.J.; Newton, J.M. Colonic delivery of 4-aminosalicylic acid using amylose-ethylcellulose coated hydroxypropylmethyl-cellulose capsules. Aliment. Pharmacol. Ther., 2002, 16, 1771-1779.
30. Zhang, H.; Alsarra, I.A.; Heau, S.H. An in vitro evaluation of a chitosan-containing multiparticulate system for macromolecule delivery to the colon. Int. J. Pharm., 2002, 239, 197-205.
31. Zambito, Y.; Colo, G.D. Preparation and in vitro evaluation of chitosan matrices for colonic controlled drug delivery. J. Pharm. Pharm. Sci., 2003, 6, 274-281.
32. Omwancha, W.; Kouba, C.; Yelamanchili, S.; Neau, S.H. Colonspecific drug delivery using ethylcellulose and chitosan in the coat of compression-coated tablets. Drug Develop. Ind. Pharm., 2011, 37, 945-953.
33. Ferrari, P.C.; Souza, F.M.; Giorgetti, L.; Oliveira, G.F.; Ferraz, H.G.; Chaud, M.V.; Evangelista, R.C. Development and in vitro evaluation of coated pellets containing chitosan to potential colonic drug delivery. Carbohydr. Polym., 2013, 91, 244-252.
34. Nunthanid, J.; Huanbutta, K.; Luangtana-anan, M.; Sriamornsak, P.; Limmatvapirat, S.; Puttipipatkhachorn, S. Development of time-, pH-, and enzyme-controlled colonic drug delivery using spraydried chitosan acetate and hydroxypropyl methylcellulose. Eur. J. Pharm. Biopharm., 2008, 68, 253-259.
35. Kaur, G.; Rana, V.; Jain, S.; Tiwary, A.K. Colon delivery of budesonide: evaluation of chitosan-chondroitin sulfate interpolymer complex. AAPS Pharm. Sci. Tech., 2010, 11, 36-45.
36. Bigucci, F.; Luppi, B.; Monaco, L.; Cerchiara, T.; Zecchi, V. Pectinbased microspheres for colon-specific delivery of vancomycin. J. Pharm. Pharmacol., 2009, 61, 41-46.
37. Vervoort, L.; Mooter, G.V.D.; Augustijns, P.; Bussons, R.; Toppet, S.; Kinget, R. Inulin hydrogels as carriers for colonic drug targeting: I. Synthesis and characterization of methacrylated inulin and hydrogel formation. Pharm. Res., 1997, 14, 1730-1737.
38. Vervoort, L.; Rombaut, P.; Mooter, G.V.D.; Augustijns, P.; Kinget, R. Inulin hydrogels. II. In vitro degradation study. Int. J. Pharm., 1998, 172, 137-145.
39. Vervoort, L.; Vinckier, I.; Moldenaers, P.; Mooter, G.V.D.; Augustijns, P.; Kinget, R. Inulin hydrogels as carriers for colonic drug targeting. Rheological characterization of the hydrogel formation and the hydrogel network. J. Pharm. Sci., 1999, 88, 209-214.
40. Akhgari, A.; Farahmand, F.; Afrasiabi Garekani, H.; Sadeghi, F.; Vandamme, T.F. Permeability and swelling studies on free films containing inulin in combination with different polymethacrylates aimed for colonic drug delivery. Eur. J. Pharm. Sci., 2006, 28, 307-314.
41. Mukherji, G.; Wilson, C.G. In: Modified release drug delivery technology, Rathbone, Hadgraft & Roberts, Eds.; Marcel Dekker: New York, 2003; pp. 233-242
42. Varshosaz, J.; Emami, J.; Fassihi, A.; Tavakoli, N.; Minaiyan, M.; Ahmadi, F.; Mahzouni, P.; Dorkoosh, F. Effectiveness of budesonide-succinate-dextran conjugate as a novel prodrug of budesonide against acetic acid-induced colitis in rats. Int. J. Colorectal Dis., 2010, 25, 1159-1165.
43. Varshosaz, J.; Ahmadi, F.; Emami, J.; Tavakoli, N.; Minaiyan, M.; Mahzouni, P.; Dorkoosh, F. Microencapsulation of budesonide with dextran by spray drying technique for colon-targeted delivery: an in vitro/ in vivo evaluation in induced colitis in rat. J. Microencapsul., 2011, 28, 62-73.
44. Wasteson, A. Properties of fractionated chondroitin sulfate from ox nasal septa. Biochem. J., 1971, 122, 477-485.
45. Sinha, V.R.; Kumria, R. Microbially triggered drug delivery to the colon. Eur. J. Pharm. Sci., 2003, 18, 3-18.
46. Rubinstein, A.; Nakar, D.; Sintov, A. Chondroitin sulfate: A potential biodegradable carrier for colon-specific drug delivery. Int. J. Pharm., 1992, 84, 141-150.
47. Sintov, A.; DiCapua, N.; Rubinstein, A. Cross-linked chondroitin sulphate: characterization for drug delivery purposes. Biomaterials, 1995, 16, 473-478.
48. Coviello, T.; Alhaique, F.; Dorigo, A.; Matricardi, P.; Grassi, M. Two galactomannans and scleroglucan as matrices for drug delivery: Preparation and release studies. Eur. J. Pharm. Biopharm., 2007, 66, 200-209.
49. Raghavan, C.V.; Muthulingam, C.; Jenita, J.A.J.L.; Ravi, T.K. An in vitro and in vivo investigation into the suitability of bacterially triggered delivery system for colon targeting. Chem. Pharm. Bull., 2002, 50, 892-895.
50. Sworn, G. In: Handbook of hydrocolloids. Phillips & Williams, Eds.; Woodhead Publishing Limited: Cambridge, 2005; pp. 103-116.
51. Sinha, V.R.; Mittal, B.R.; Bhutani, K.K.; Kumria, R. Colonic drug delivery of 5-fluorouracil: an in vitro evaluation. Int. J. Pharm., 2004, 269, 101-108.
52. Sinha, V.R.; Mittal, B.R.; Kumria, R. in vivo evaluation of time and site of disintegration of polysaccharide tablet prepared for colon-specific drug delivery. Int. J. Pharm., 2005, 289, 79-85.
53. Takigami, S. In: Handbook of hydrocolloids, Phillips & Williams, Eds.: Woodhead Publishings Limited: Cambridge, 2000; pp. 413-424.
54. Liu, J.; Zhang, L.; Hu, W.; Tain, R.; Teng, Y.; Wang, C. Preparation of konjac glucomannan-based pulsatile capsule for colonic drug delivery system and its evaluation in vitro and in vivo. Carbohydr. Polym., 2012, 87, 377-382.
55. Mancenido, F.A.; Landin, M.; Pacheco, R.M. Konjac glucomannan/ xanthan gum enzyme sensitive binary mixtures for colonic drug delivery. Eur. J. Pharm. Biopharm., 2008, 69, 573-581.
56. Kulkarni, N.; Shendye, A.; Rao, M. Molecular and biotechnological aspects of xylanases. FEMS Microbiol. Rev., 1999, 23, 411-456.
57. Silva, A.E.; Marceline, H.R.; Gomes, M.C.S.; Oliveira, E.E.; Nagashima Jr., T.; Egito, E.S.T. In: Products and applications of biopolymers, Verbeck, Ed.: InTech Publishing: Shanghai, 2012; pp. 61-84.
58. Kumar, S.; Negi, Y.S. Nanoparticles synthesis from corn cob (Xylan) and their potential application as colon-specific drug carrier. Macromol. Symp., 2012, 320, 75-80.
59. Tonnesen, H.H.; Karlsen, J. Alginates in drug delivery systems. Drug Develop. Ind. Pharm., 2002, 28, 621-630.
60. Dragnet, K.I. In: Handbook of hydrocolloids, Phillips & Williams, Eds.: Woodhead Publishing Limited: Cambridge, 2000; pp. 379-396
61. Hsu, F.Y.; Yu, D.S.; Huang, C.C. Development of pH-sensitive pectinate/alginate microspheres for colon drug delivery. J. Mater. Sci. Mater. Med., 2013, 24, 317-323.
62. Mladenovska, R.; Raicki, R.S.; Janevik, E.I.; Rostocki, T.; Pavlova, M.J.; Kavrakovski, Z., Dodov, M.G.; Goracinova, K. Colonspecific delivery of 5-aminosalicylic acid from chitosan-Caalginate microparticles. Int. J. Pharm., 2007, 342, 124-136
63. Adeyeye, M.C. In: Preformulation in solid dosage form development, Adeyeye & Brittain, Eds.: Informa Healthcare USA: New York, 2008; pp. 357-436.
64. Buckton, G. In: Modern Pharmaceutics, Florence & Siepmann, Eds.: Informa Healthcare USA: New York, 2009; Vol. 1, pp. 311-326.
65. Yehia, S.A.; Elshafeey, A.H.; Sayed, I.; Shehata, A.H. Optimization of budesonide compression-coated tablets for colonic delivery. AAPS PharmSciTech., 2009, 10, 147-157.
66. Mundargi, R.C.; Patil, S.A.; Agnihotri, S.A.; Aminabhavi, T.M. Development of polysaccharide-based colon targeted drug delivery systems for the treatment of amoebiasis. Drug Develop. Ind. Pharm., 2007, 33, 255-264.
67. Kshirsagar, S.J.; Bhalekar, M.R.; Pawar, R.P. In vitro drug release and in vivo human X-ray studies of ileo-cecal targeting budesonide fast disintegrating tablet. Drug Develop. Ind. Pharm., 2009, 35, 788-795.
68. Kumar, S.R.; Piyush, T.; Suman, R.; Akanksha, T. Preparation and characterization of cross-linked guar gum microspheres: Optimization using factorial design. Chem. Pharm. Bull., 2011, 59, 185-190.
69. Paharia, A.; Yadav, A.K.; Rai, G.; Jain, S.K.; Pancholi, S.S.; Agrawal, G.P. Eudragit-coated pectin microspheres of 5-fluorouracil for colon targeting. AAPS Pharm. Sci. Tech., 2007, 8, Article 12.
70. Freire, C.; Podczeck, F. Ferreira, D.; Veiga, F.; Sousa, J.; Pena, A. Assessment of the in-vivo drug release from pellets film-coated with a dispersion of high amylose starch and ethylcellulose for potential colon delivery. J. Pharm. Pharmacol., 2010, 62, 55-61.
71. McConnell, E.L.; Tutas, J.; Mohamed, M.A.M.; Banning, D.; Basit, A.W. Colonic drug delivery using amylose films: the role of aqueous ethylcellulose dispersions in controlling drug release. Cellulose, 2007, 14, 25-34.
72. Blumberg, R.S.; Saubermann, L.J.; Strober, W. Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Curr. Opin. Immunol., 1999, 11, 648-656.
73. El-Kamel, A.H.; Abdel-Aziz, A.M.; Fatani, A.J.; El-Subbagh, H.I. Oral colon targeted delivery systems for treatment of inflammatory bowel diseases: Synthesis, in vitro and in vivo assessment. Int. J. Pharm., 2008, 358, 248-55.
74. Hagar, H.H.; Medany, A.E.; Eter, E.E.; Arafa, M. Ameliorative effect of pyrrolidinedithiocarbamate on acetic acid-induced colitis in rats. Eur. J. Pharmacol., 2007, 554, 69-77.
75. Makhlof, A.; Tozuka, Y.; Takeuchi, H. pH-Sensitive nanospheres for colon-specific drug delivery in experimentally induced colitis rat model. Eur. J. Pharm. Biopharm., 2009, 72, 1-8.
76. Kim, T.W.; Seo, J.N.; Suh, Y.H.; Park, H.J.; Kim, J.H.; Kim, J.Y.; Oh, K.I. Involvment of lymphocytes in dextran sulfate sodiuminduced experimental colitis. World J. Gastroenteraol., 2006, 12, 302-305
77. Wei, H.; Qing, D.; Ying, C.D.; Bai, X.; Fang, F.L. In-vitro and in-vivo studies of pectin/ethylcellulose film-coated pellets of 5-fluorouracil for colonic targeting. J. Pharm. Pharmacol., 2008, 60, 35-44.
78. Fan, L.F.; He, W.; Bai, M.; Du, Q.; Xiang, B.; Chang, Y.Z.; Cao, D.Y. Biphasic drug release: permeability and swelling of pectin/ ethylcellulose films, and in vitro and in vivo correlation of filmcoated pellets in dogs. Chem. Pharm. Bull., 2008, 56, 1118-1125.
79. Krishnaiah, Y.S.R.; Muzib, I.; Bhaskar, P. In Vivo Evaluation of Guar Gum-based Colon-targeted Drug Delivery Systems of Ornidazole in Healthy Human Volunteers. J. Drug Target., 2003, 11, 109-115.
80. Zimova, L.O.; Vetchy, D.; Muselik, J.; Stembirek, J. The development and in vivo evaluation of a colon drug delivery system using human volunteers. Drug Deliv., 2012, 19, 81-89.
81. Sandborn, W.J.; Hanauer, S.B. Systematic review: the pharmacokinetic profiles of oral mesalazine formulations and mesalazine pro-drugs used in the management of ulcerative colitis. Aliment. Pharmacol. Ther., 2003, 17, 29-42.
82. Rao, K.P.; Prabhashankar, B.; Kumar, A.; Khan, A.; Biradar, S.S.; Srishail, S.P.; Satyanath, B. Formulation and roentgenographic studies of naproxen-pectin based matrix tablets for colon drug delivery. Yale J. Biol. Med., 2003, 76, 149-154.
83. Yassin, A.E.B.; Alsarra, I.A.; Alanazi, F.K.; Al-Mohizea, A.M.; Al-Robayan, Al-Obeed, O.A. New targeted-colon delivery system: in vitro and in vivo evaluation using X-ray imaging. J. Drug Target., 2010, 18, 59-66.
84. Sangalli, M.E.; Maroni, A.; Zema, L.; Busetti, C.; Giordano, F.; Gazzaniga, A. In vitro and in vivo evaluation of an oral system for time and/or site-specific drug delivery. J. Control. Rel., 2001, 73, 103-110.
85. McConnell, E.L.; Short, M.D.; Basit, A. An in vivo comparison of intestinal pH and bacteria as physiological trigger mechanisms for colonic targeting in man. J. Control. Rel., 2008 130, 154-160.
86. Wilding, I.R.; Behrens, C.; Tardif, S.J.; Wray, H.; Bias, P.; Albrecht, W. Combined scintigraphic and pharmacokinetic investigation of enteric-coated mesalazine micropellets in healthy subjects. Aliment. Pharmacol. Ther., 2003, 17, 1153-1162.
87. Basit, A.W.; Podczeck, F.; Newton, J.M.; Waddington, W.A.; Ell, P.J.; Lacey, L.F. The use of formulation technology to assess regional gastrointestinal drug absorption in humans. Eur. J. Pharm. Sci., 2004, 21, 179-189.